• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在现实环境中,对弱势群体进行公平的优先疫苗接种是否可行?以比利时为例。

Is equitable priority vaccination of vulnerable people feasible in a real-world context? The case of Belgium.

作者信息

Vermeiren Elias, Scheerens Charlotte, Stouten Veerle, Crombez John, De Maeseneer Jan, van Loenhout Joris A F

机构信息

Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium.

Department of Public Health and Primary Care, Ghent University, Ghent, Belgium.

出版信息

Eur J Public Health. 2025 Aug 1;35(4):774-780. doi: 10.1093/eurpub/ckaf075.

DOI:10.1093/eurpub/ckaf075
PMID:40493534
Abstract

Belgium has implemented a strategy to prioritize vaccination at population level during the COVID-19 pandemic, targeting individuals with pre-existing health conditions at increased risk of severe COVID-19. We aimed to evaluate whether prioritized groups were vaccinated sooner, and which socio-demographic and -economic characteristics were related to the speed of vaccine uptake. We calculated the time to vaccination between the start of the prioritization (1 April 2021) and receiving a first COVID-19 vaccine dose, using this interval as a proxy for evaluating the strategy's early impact. A multivariate regression model, incorporating priority status, age, sex, region of residence, income, and migration background, described the natural logarithm of this time gap. The sample included 4 472 873 individuals vaccinated between 1 April and 31 December 2021, of which 26.4% were prioritized. The results show a 34.6 days earlier vaccination for prioritized individuals versus non-prioritized ones. The time difference between the prioritized and non-prioritized groups was larger in the younger age groups compared to the older age groups (28.2 days versus 19.3 days). Based on the multivariate model estimates, being prioritized [βpriority = -0.37, 95% CI (-0.38; -0.36)], older age [β55-64 = -0.57, 95% CI(-0.58; -0.56)], residency in Brussels or Wallonia [βBrussels = -0.18, 95%CI (-0.20; -0.16); βWallonia = -0.18, 95% CI (-0.19; -0.17)], having a high income [βhigh income = -0.11, 95% CI (-0.12; -0.10)], being a Belgian national (βbelgian = reference), having had a recent prior infection (βno prior infection = reference) and being female (βfemale = reference) are associated with a shorter time to vaccination. Developing and implementing a prioritization vaccination strategy accelerated vaccination for the high-risk population with health conditions, demonstrating its feasibility in promoting equitable access to COVID-19 vaccines.

摘要

在新冠疫情期间,比利时实施了一项在人群层面优先接种疫苗的策略,目标是那些已有健康状况且感染新冠病毒后患重症风险增加的人群。我们旨在评估优先接种群体是否更早接种了疫苗,以及哪些社会人口和经济特征与疫苗接种速度相关。我们计算了从优先接种开始(2021年4月1日)到接种第一剂新冠疫苗之间的时间,并以此间隔作为评估该策略早期影响的指标。一个多元回归模型纳入了优先地位、年龄、性别、居住地区、收入和移民背景,描述了这个时间间隔的自然对数。样本包括2021年4月1日至12月31日期间接种疫苗的4472873人,其中26.4%属于优先接种群体。结果显示,优先接种群体比非优先接种群体提前34.6天接种疫苗。与年龄较大的群体相比,年龄较小的群体中优先接种群体和非优先接种群体之间的时间差异更大(28.2天对19.3天)。根据多元模型估计,被列为优先接种对象[β优先 = -0.37,95%置信区间(-0.38;-0.36)]、年龄较大[β55 - 64 = -0.57,95%置信区间(-0.58;-0.56)]、居住在布鲁塞尔或瓦隆地区[β布鲁塞尔 = -0.18,95%置信区间(-0.20;-0.16);β瓦隆 = -0.18,95%置信区间(-0.19;-0.17)]、高收入[β高收入 = -0.11,95%置信区间(-0.12;-0.10)]、是比利时国民(β比利时 = 参照)、近期无既往感染(β无既往感染 = 参照)以及女性(β女性 = 参照)与较短的接种时间相关。制定和实施优先接种策略加快了有健康状况的高危人群的疫苗接种速度,证明了其在促进公平获得新冠疫苗方面的可行性。

相似文献

1
Is equitable priority vaccination of vulnerable people feasible in a real-world context? The case of Belgium.在现实环境中,对弱势群体进行公平的优先疫苗接种是否可行?以比利时为例。
Eur J Public Health. 2025 Aug 1;35(4):774-780. doi: 10.1093/eurpub/ckaf075.
2
The effect of sample site and collection procedure on identification of SARS-CoV-2 infection.样本采集部位和采集程序对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染鉴定的影响。
Cochrane Database Syst Rev. 2024 Dec 16;12(12):CD014780. doi: 10.1002/14651858.CD014780.
3
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
4
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
5
COVID-19 Vaccine Effectiveness in Autumn and Winter 2022 to 2023 Among Older Europeans.2022 年至 2023 年秋冬期间,老年欧洲人群中的 COVID-19 疫苗有效性。
JAMA Netw Open. 2024 Jul 1;7(7):e2419258. doi: 10.1001/jamanetworkopen.2024.19258.
6
Disparities in Preventive Care Utilization at the Intersection of Socioeconomic and Demographic Characteristics: A Survival Analysis of COVID-19 Vaccination Uptake in the United States.社会经济和人口特征交叉点上预防性保健利用的差异:美国新冠疫苗接种情况的生存分析
J Public Health Manag Pract. 2025;31(5):726-736. doi: 10.1097/PHH.0000000000002151. Epub 2025 Jul 17.
7
Physical interventions to interrupt or reduce the spread of respiratory viruses.物理干预措施以阻断或减少呼吸道病毒的传播。
Cochrane Database Syst Rev. 2023 Jan 30;1(1):CD006207. doi: 10.1002/14651858.CD006207.pub6.
8
Investigation and analysis of mental health status of the older adult in western rural areas.西部农村地区老年人心理健康状况的调查与分析
Front Public Health. 2025 Jul 16;13:1612600. doi: 10.3389/fpubh.2025.1612600. eCollection 2025.
9
Use of complementary medicine and its association with SARS-CoV-2 vaccination during the COVID-19 pandemic: a longitudinal cohort study.在 COVID-19 大流行期间使用补充医学及其与 SARS-CoV-2 疫苗接种的关系:一项纵向队列研究。
Swiss Med Wkly. 2023 Dec 18;153:3505. doi: 10.57187/s.3505.
10
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.

本文引用的文献

1
Socio-demographic determinants of COVID-19 vaccine uptake in Ontario: Exploring differences across the Health Region model.安大略省新冠疫苗接种的社会人口学决定因素:探究健康区域模式下的差异
Vaccine. 2024 Mar 19;42(8):2106-2114. doi: 10.1016/j.vaccine.2024.02.045. Epub 2024 Feb 26.
2
Sociodemographic and socioeconomic disparities in COVID-19 vaccine uptake in Belgium: a nationwide record linkage study.比利时新冠疫苗接种中的社会人口学和社会经济差异:一项全国性记录关联研究。
J Epidemiol Community Health. 2023 Dec 26;78(3):176-83. doi: 10.1136/jech-2023-220751.
3
Factors underlying COVID-19 booster vaccine uptake among adults in Belgium.
比利时成年人接种 COVID-19 加强疫苗的因素。
BMC Res Notes. 2023 Nov 11;16(1):328. doi: 10.1186/s13104-023-06608-4.
4
Neighbourhood sociodemographic factors and COVID-19 vaccine uptake in the Netherlands: an ecological analysis.社区社会人口因素与荷兰 COVID-19 疫苗接种率:一项生态分析。
BMC Public Health. 2023 Sep 2;23(1):1696. doi: 10.1186/s12889-023-16600-z.
5
Socio-demographic characteristics associated with COVID-19 vaccination uptake in Switzerland: longitudinal analysis of the CoMix study.与瑞士 COVID-19 疫苗接种率相关的社会人口学特征:CoMix 研究的纵向分析。
BMC Public Health. 2023 Aug 10;23(1):1523. doi: 10.1186/s12889-023-16405-0.
6
COVID-19 vaccine effectiveness against symptomatic infection and hospitalisation in Belgium, July 2021 to May 2022.比利时 2021 年 7 月至 2022 年 5 月期间 COVID-19 疫苗对有症状感染和住院的有效性。
Euro Surveill. 2023 Jun;28(26). doi: 10.2807/1560-7917.ES.2023.28.26.2200768.
7
Determinants of Covid-19 vaccination: Evidence from the US pulse survey.新冠疫苗接种的决定因素:来自美国脉冲调查的证据。
PLOS Glob Public Health. 2023 May 18;3(5):e0001927. doi: 10.1371/journal.pgph.0001927. eCollection 2023.
8
Determinants of COVID-19 skepticism and SARS-CoV-2 vaccine hesitancy: findings from a national population survey of U.S. adults.新冠病毒怀疑论和 SARS-CoV-2 疫苗犹豫的决定因素:来自美国成年人全国性人口调查的结果。
BMC Public Health. 2022 May 25;22(1):1047. doi: 10.1186/s12889-022-13477-2.
9
Monitoring sociodemographic inequality in COVID-19 vaccination uptake in England: a national linked data study.监测英格兰新冠疫苗接种中的社会人口不平等:一项全国性关联数据研究。
J Epidemiol Community Health. 2022 Jul;76(7):646-652. doi: 10.1136/jech-2021-218415. Epub 2022 Apr 25.
10
COVID-19 vaccination uptake amongst ethnic minority communities in England: a linked study exploring the drivers of differential vaccination rates.英格兰少数族裔社区的 COVID-19 疫苗接种率:一项探索差异接种率驱动因素的关联研究。
J Public Health (Oxf). 2023 Mar 14;45(1):e65-e74. doi: 10.1093/pubmed/fdab400.